Cannabis Investors: Can Hexo (TSX:HEXO) Stock Make a Comeback in 2021?

Will Hexo’s (TSX:HEXO) strong cannabis-infused beverage sales help drive its stock price higher in 2021?

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Another year has gone by that sees cannabis stocks underperforming the broader markets by a huge margin. Shares of Hexo (TSX:HEXO)(NYSE:HEXO) are trading at $1.37, which meant it has lost close to a quarter of its market value in 2020. Hexo stock is also trading 87% below its all-time high price.

However, since the start of November, Hexo shares have risen 70% to trade at the current price. Does this mean it can gain momentum in 2021 and continue its upward spiral?

Is Hexo stock a buy?

Hexo is a Canada-based marijuana company and recently released its fiscal fourth-quarter results (ending in July). The company reported net revenue of $27.1 million, a growth of 76% year-over-year and 23% on a sequential basis.

This stellar performance was supported by its adult-use beverages segment that accounted for $2 million in sales, up from just $431,000 in the third quarter. Hexo’s non-beverage sales also gained pace and rose by 16% to $25.1 million.

Hexo announced a joint venture with Molson Coors back in 2018 in order to gain traction in Canada’s cannabis-infused beverage market. The joint venture, Truss, launched five new brands in 2020, offering consumers multiple beverage options.

However, similar to most peer companies, Hexo is also grappling with negative profit margins. In Q4, Hexo’s net loss stood at $169.5 million, up $18.8 million year-over-year. Hexo attributed the losses to goodwill impairments and inventory write-downs.

After accounting for non-cash items, investment gains, and other adjustments, Hexo’s EBITDA loss stands at $3.3 million. Alternatively, investors should also note that the company is struggling to sell its inventory which indicates a loss in market share or lower than estimated demand.

In Q4, Hexo produced 16,540 kilograms of dried cannabis but sold just 50% of its production. This trend has been visible for close to five quarters where Hexo has consistently sold less cannabis compared to the amount it harvested. We can see why Hexo is struggling with lackluster demand and massive asset write-downs.

A major driver for Hexo stock

Marijuana stocks have gained pace in the last month after Joe Biden won the presidential race. During one of the pre-election debates, Vice President-elect Kamala Harris said the Democrats would decriminalize the use of marijuana at the federal level, which drove the pot market rally.

The legalization of cannabis south of the border will be one of the major drivers of Hexo’s stock price. This legalization may take a few years to materialize which suggests Hexo should focus on gaining market share and reducing losses in the Canadian market.

Hexo stock has a market cap of $660 million, which means its trading at a forward price to sales multiple of 4.96. Analysts also expect the company’s earnings loss to narrow from $1.77 per share in fiscal 2020 to $0.03 in fiscal 2022.

Comparatively, its sales are forecast to grow by 65% to $133.5 million in 2021 and by 30% to $173 million in 2022. We can see that Hexo is reasonably valued, especially if it can improve the bottom line and remain consistently profitable.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »